Compare AOSL & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AOSL | FLGT |
|---|---|---|
| Founded | 2000 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 940.9M | 867.4M |
| IPO Year | 2010 | 2016 |
| Metric | AOSL | FLGT |
|---|---|---|
| Price | $22.57 | $28.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $24.33 | ★ $28.33 |
| AVG Volume (30 Days) | ★ 308.9K | 210.0K |
| Earning Date | 02-05-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $696,776,000.00 | $315,549,000.00 |
| Revenue This Year | N/A | $16.84 |
| Revenue Next Year | $6.59 | $9.74 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 5.81 | ★ 13.61 |
| 52 Week Low | $15.90 | $14.57 |
| 52 Week High | $46.65 | $31.04 |
| Indicator | AOSL | FLGT |
|---|---|---|
| Relative Strength Index (RSI) | 61.53 | 56.71 |
| Support Level | $21.86 | $27.39 |
| Resistance Level | $22.56 | $28.44 |
| Average True Range (ATR) | 0.70 | 0.79 |
| MACD | 0.22 | 0.19 |
| Stochastic Oscillator | 77.84 | 80.41 |
Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries. It operates in one operating segment: the design, development and supply of power semiconductor products for computing, consumer electronics, communication and industrial applications.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.